Infigratinibphosphate
| Infigratinibphosphate | |
|---|---|
| Term | Infigratinibphosphate |
| Short definition | Infigratinibphosphate (IN-fig-RA-tih-nib FOS-fayt) A drug used to treat adults with cholangiocarinoma (bile duct cancer) that is locally advanced and cannot be surgically removed or spread to has spread to other parts of the body. It is used in patients whose cancer has a FGFR2 gene fusion or other change in the structure of the FGFR2 gene and has already been treated. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Infigratinibphosphate - (pronounced) (IN-fig-RA-tih-nib FOS-fayt) A drug used to treat adults with cholangiocarinoma (bile duct cancer) that is locally advanced and cannot be surgically removed or spread to has spread to other parts of the body. It is used in patients whose cancer has a FGFR2 gene fusion or other change in the structure of the FGFR2 gene and has already been treated. It is also being studied in the treatment of other types of cancer. Infigratinib phosphate blocks a protein called FGFR, which can help prevent cancer cells from growing and kill them. It can also prevent the growth of new blood vessels that tumors need to grow. Infigratinib phosphate is a type of tyrosine kinase inhibitor and a type of anti-angiogenesis drug. Also called Truseltiq
External links
- Medical encyclopedia article on Infigratinibphosphate
- Wikipedia's article - Infigratinibphosphate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski